Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Revelation Biosciences, Inc. - Common Stock
(NQ:
REVB
)
0.3024
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,107
Open
0.3024
Bid (Size)
0.2900 (15)
Ask (Size)
0.3100 (1)
Prev. Close
0.3024
Today's Range
0.3024 - 0.3024
52wk Range
0.2810 - 25.26
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 03, 2024
Via
Benzinga
Why Revelation Biosciences (REVB) Stock Is Down 38%
December 03, 2024
Revelation Biosciences shares are trading lower by 38% during Tuesday's session. The company agreed to a $4M warrant exercise, closing December 3.
Via
Benzinga
Performance
YTD
-98.02%
-98.02%
1 Month
-59.28%
-59.28%
3 Month
-58.02%
-58.02%
6 Month
-87.40%
-87.40%
1 Year
-98.04%
-98.04%
More News
Read More
Revelation Biosciences Inc. Announces Exercise of Warrants for $4 Million in Gross Proceeds
December 03, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Revelation Biosciences Inc. Announces FDA Acceptance of Gemini IND
December 02, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Revelation Biosciences, Inc. Completes the GMP Manufacture of Gemini Clinical Drug Supply
November 12, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 11, 2024
Via
Benzinga
Why Revelation Biosciences Shares Are Trading Higher By Around 49%; Here Are 20 Stocks Moving Premarket
November 11, 2024
Via
Benzinga
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2024
November 08, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Revelation Biosciences’ Gemini Induces Dose Dependent Significant Increases in IL-10
September 24, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Nasdaq Down Over 200 Points; Williams-Sonoma Shares Tumble After Q2 Results
August 22, 2024
Via
Benzinga
Gold Down Over 1%; US Initial Jobless Claims Increase
August 22, 2024
Via
Benzinga
Dow Jumps 100 Points; BJ's Wholesale Earnings Top Estimates
August 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Wolfspeed Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
August 22, 2024
Via
Benzinga
Revelation Biosciences Inc. Announces Exercise of Warrants for $3.8 Million in Gross Proceeds
August 21, 2024
From
Revelation Biosciences Inc.
Via
Business Wire
US Stocks Higher; Target Posts Upbeat Earnings
August 21, 2024
Via
Benzinga
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
August 21, 2024
Via
Benzinga
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
August 14, 2024
Via
Benzinga
REVB Stock Earnings: Revelation Biosciences Misses EPS for Q2 2024
August 09, 2024
Via
InvestorPlace
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2024
August 09, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Why Is Nano-Cap Revelation Biosciences Stock Skyrocketing On Monday?
June 24, 2024
Via
Benzinga
Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
June 24, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini
June 13, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
May 17, 2024
Via
Benzinga
REVB Stock Earnings: Revelation Biosciences Misses EPS for Q1 2024
May 10, 2024
Via
InvestorPlace
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024
May 10, 2024
From
Revelation Biosciences, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.